FDA's Patient-Centered Drug Center

The new Prescription Drug User Fee Agreement includes a host of new projects, of varying potential impact. But it is clear that a plan to host a series of disease-specific meetings to identify key risk/benefit goals of patients is one of the most important from FDA’s perspective.